Answers are grounded in this paper and cite their sources.
Ruthenium(II) complexes have emerged as effective catalysts for C–H arylations of tetrazolyl-substituted arenes by chelation assistance. Particularly, bifunctional additives, such as carboxylates or phosphates, set the stage for versatile C–H functionalizations with organic halides, which allowed for the step-economical synthesis of angiotensin-II-receptor blockers (ARBs) with unprecedented levels of efficacy and substrate scope. The outstanding robustness of the ruthenium(II) complexes was among others illustrated by remarkably low catalyst loadings and applications of this technology on a preparative scale.
No takes yet. Share an insight, caveat, or question.
Lutz Ackermann (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: